Filter Results
:
(1,001)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business...
View Details
Jack M. Eckerd
Eckerd introduced the self-service retailing model in his drug store operations and, in the process, built the largest drug store retail chain in the South. Eckerd was one of the firsts to recognize the...
View Details
Keywords:
Retail
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from...
View Details
- 01 Dec 2019
- News
The Race Against Resistance
tide. “If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people. Can you imagine? That’s a bit of a doomsday perspective, but it’s a call to action.” “We are approaching...
View Details
Keywords:
Lisa Scanlon Mogolov
- 01 Sep 2004
- News
Bill Dunaway (MBA 1964)
A self-described SOB — son of the boss — Bill Dunaway grew up working in his father’s pharmacy in Marietta, Georgia, a town of 61,000 outside Atlanta. After expanding the business to a chain of 18 drug stores, Dunaway sold the operation...
View Details
- Web
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows - MBA
Blog Blog MBA Voices Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Career and Professional Development Staff Author HBS Community Author HBS Faculty Author MBA Admissions Author MBA Students Topics Topics 1st Year (RC) 2+2 Program 2nd Year...
View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more...
View Details
Keywords:
by Sean Silverthorne
- 01 Sep 2008
- News
Mara Aspinall
higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring...
View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit...
View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks...
View Details
Keywords:
Margie Kelley
- 09 Aug 2016
- First Look
August 9, 2016
https://www.hbs.edu/faculty/Pages/item.aspx?num=51304 The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or...
View Details
Keywords:
Sean Silverthorne
- 01 Jun 2012
- News
The Power of Philanthropy
announced its approval of Kalydeco, a drug produced by Vertex that will immediately help some 1,200 cystic fibrosis patients and is viewed as a breakthrough precursor drug to forthcoming products that will...
View Details
Stanley P. Goldstein
In 1969, Goldstein’s drug store chain, CVS, was acquired by Melville Corporation and soon became the conglomerate’s dominant retail establishment. Goldstein took the reins of Melville in 1987 and began a total restructuring program...
View Details
Keywords:
Retail
Thomas M. Rauch
Through significant investments in research and development, Rauch enabled Smith Kline to build a pipeline of new products and drug applications. During his leadership, Smith Kline’s revenues increased from $259 million to $357 million –...
View Details
Keywords:
Healthcare
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are spending several...
View Details
Keywords:
by Manda Salls
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high...
View Details
- 01 Mar 2012
- News
How to Close the Health Gap
the efforts of scientists, health organizations, businesses, and philanthropists to extend the frontiers of medicine and in particular the science of genomics beyond the Northern Hemisphere and into rural villages the world over. It turns out to be a particularly...
View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech...
View Details
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
can be found in company’s income statement that can be found in Capital IQ ABI/ProQuest - To locate articles on the topic, use search terms: drug development cost (drug development) AND (success rates)
View Details
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Cambridge, Massachusetts, and you will likely be administered beta blockers, a class of drug that's generally recommended after a heart attack. The rate at which that drug is delivered nationwide, however,...
View Details